000			02070 a2200553 4500
005			20250517184551.0
264		0	_c20190321
008			201903s 0 0 eng d
022			_a1872-6623
024	7		_a10.1097/j.pain.0000000000001106 _2doi
040			_aNLM _beng _cNLM
100	1		_aDoolen, Suzanne
245	0	0	_aFingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn. _h[electronic resource]
260			_bPain _c02 2018
300			_a224-238 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnilides _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCentral Nervous System Sensitization _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aFingolimod Hydrochloride _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aMultiple Sclerosis _xchemically induced
650	0	4	_aMyelin-Oligodendrocyte Glycoprotein _xtoxicity
650	0	4	_aNeuralgia _xdrug therapy
650	0	4	_aOrganophosphonates _xpharmacology
650	0	4	_aOxadiazoles _xpharmacology
650	0	4	_aPain Threshold _xdrug effects
650	0	4	_aPeptide Fragments _xtoxicity
650	0	4	_aReceptors, Lysosphingolipid _xmetabolism
650	0	4	_aSphingosine-1-Phosphate Receptors
650	0	4	_aSpinal Cord _xmetabolism
650	0	4	_aSpinal Nerve Roots _xdrug effects
650	0	4	_aSubcellular Fractions _xdrug effects
650	0	4	_aThiophenes _xpharmacology
650	0	4	_aeIF-2 Kinase _xmetabolism
700	1		_aIannitti, Tommaso
700	1		_aDonahue, Renee R
700	1		_aShaw, Benjamin C
700	1		_aGrachen, Carolyn M
700	1		_aTaylor, Bradley K
773	0		_tPain _gvol. 159 _gno. 2 _gp. 224-238
856	4	0	_uhttps://doi.org/10.1097/j.pain.0000000000001106 _zAvailable from publisher's website
999			_c27791246 _d27791246